Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
MyMD Pharmaceuticals (MYMD)
NASDAQ:MYMD
Holding MYMD?
Track your performance easily
MYMD Stock Chart & Stats
Day’s Range$1.78 - $1.84
52-Week Range― - ―
Previous Close$1.82
Volume24.35K
Average Volume (3M)N/A
Market Cap
$4.55M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
May 20, 2019EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
MyMD Pharmaceuticals News
PremiumCompany Announcements
MyMD Pharmaceuticals Rebrands as TNF Pharmaceuticals
PremiumCompany Announcements
MyMD Pharmaceuticals Enhances Governance and Financing StructureOwnership Overview
0.00% Insiders
0.00% Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MYMD FAQ
What was MyMD Pharmaceuticals’s price range in the past 12 months?
Currently, no data Available
What is MyMD Pharmaceuticals’s market cap?
Currently, no data Available
When is MyMD Pharmaceuticals’s upcoming earnings report date?
MyMD Pharmaceuticals’s upcoming earnings report date is May 20, 2019 which is 2017 days ago.
How were MyMD Pharmaceuticals’s earnings last quarter?
MyMD Pharmaceuticals released its earnings results on Apr 01, 2019. The company reported -$3.526 earnings per share for the quarter, missing the consensus estimate of N/A by -$3.526.
Is MyMD Pharmaceuticals overvalued?
According to Wall Street analysts MyMD Pharmaceuticals’s price is currently Overvalued.
Does MyMD Pharmaceuticals pay dividends?
MyMD Pharmaceuticals does not currently pay dividends.
What is MyMD Pharmaceuticals’s EPS estimate?
MyMD Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MyMD Pharmaceuticals have?
Currently, no data Available
What happened to MyMD Pharmaceuticals’s price movement after its last earnings report?
MyMD Pharmaceuticals reported an EPS of -$3.526 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of MyMD Pharmaceuticals?
Currently, no hedge funds are holding shares in MYMD
---
MyMD Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.9%
Last 30 Days ▲ 2.4%
Last 30 Days ▲ 2.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-94.43%
12-Months-Change
Fundamentals
Return on Equity
-105.32%
Trailing 12-Months
Asset Growth
-48.98%
Trailing 12-Months
Company Description
MyMD Pharmaceuticals
Akers Biosciences, Inc. develops health information technologies. It engages in the developing, manufacturing, and supplying screening and testing products to deliver healthcare information to consumers and healthcare providers. Its products include clinical diagnostics, safety diagnostics, wellness products, and tests in development. The company was founded by Raymond Francis Akers, Jr. and Raymond F. Akers, Sr. on March 8, 1989 and is headquartered in West Deptford, NJ.
---
Technical Analysis
---